|
1
|
East JE and Dekker E: Colorectal cancer
diagnosis in 2012: A new focus for CRC prevention-more serration,
less inflammation. Nat Rev Gastroenterol Hepatol. 10:69–70. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Andrews L: Dietary flavonoids for the
prevention of colorectal cancer. Clin J Oncol Nurs. 17:671–672.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Altobelli E, Lattanzi A, Paduano R,
Varassi G and di Orio F: Colorectal cancer prevention in Europe:
Burden of disease and status of screening programs. Prev Med.
62:132–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sugarbaker PH: Colorectal cancer:
Prevention and management of metastatic disease. Biomed Res Int.
2014:7828902014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan DS, Lau R, Aune D, Vieira R,
Greenwood DC, Kampman E and Norat T: Red and processed meat and
colorectal cancer incidence: Meta-analysis of prospective studies.
PLoS One. 6:e204562011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wei ZJ, Tao ML, Zhang W, Han GD, Zhu ZC,
Miao ZG, Li JY and Qiao ZB: Up-regulation of microRNA-302a
inhibited the proliferation and invasion of colorectal cancer cells
by regulation of the MAPK and PI3K/Akt signaling pathways. Int J
Clin Exp Pathol. 8:4481–4491. 2015.PubMed/NCBI
|
|
8
|
Amano R, Yamada N, Nakata B, Kimura K,
Yashiro M, Ohira M and Hirakawa K: Prognostic indicator for the
resection of liver metastasis of colorectal cancer. Surg Today.
44:1287–1292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lieberman DA, Rex DK, Winawer SJ,
Giardiello FM, Johnson DA and Levin TR: Guidelines for colonoscopy
surveillance after screening and polypectomy: A consensus update by
the US multi-society task force on colorectal cancer.
Gastroenterology. 143:844–857. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lai EC: Micro RNAs are complementary to 3′
UTR sequence motifs that mediate negative post-transcriptional
regulation. Nat Genet. 30:363–364. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ostenfeld MS, Bramsen JB, Lamy P,
Villadsen SB, Fristrup N, Sørensen KD, Ulhøi B, Borre M, Kjems J,
Dyrskjøt L and Orntoft TF: miR-145 induces caspase-dependent and
-independent cell death in urothelial cancer cell lines with
targeting of an expression signature present in Ta bladder tumors.
Oncogene. 29:1073–1084. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lai VK, Ashraf M, Jiang S and Haider K:
MicroRNA-143 is a critical regulator of cell cycle activity in stem
cells with co-overexpression of Akt and angiopoietin-1 via
transcriptional regulation of Erk5/cyclin D1 signaling. Cell Cycle.
11:767–777. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu D, Zhou Y, Pan H, Zhou J, Fan Y and Qu
P: microRNA-99a inhibiting cell proliferation, migration and
invasion by targeting fibroblast growth factor receptor 3 in
bladder cancer. Oncol Lett. 7:1219–1224. 2014.PubMed/NCBI
|
|
16
|
Wu WB, Wang W, Du YH, Li H, Xia SJ and Liu
HT: MicroRNA-3713 regulates bladder cell invasion via MMP9. Sci
Rep. 6:323742016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng S, Zhu X, Fan B, Xie D, Li T and
Zhang X: miR-19a-3p targets PMEPA1 and induces prostate cancer cell
proliferation, migration and invasion. Mol Med Rep. 13:4030–4038.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu J, Cui H, Zhu Z and Wang L:
MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and
inhibits tumor growth of glioma through down-regulation of ERK5.
Biochem Biophys Res Commun. 478:1158–1164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Xiong M, Hu Y, Sun Y and Ma Q:
MicroRNA-19b inhibits proliferation of gastric cancer cells by
targeting B-cell CLL/lymphoma 3. Oncol Rep. 36:2079–2086. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong J, Liu Y, Liao W, Liu R, Shi P and
Wang L: miRNA-223 is a potential diagnostic and prognostic marker
for osteosarcoma. J Bone Oncol. 5:74–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:pp. 2257–2261.
2006; View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Q, Cheng Q, Chen Z, Peng R, Chen R, Ma
Z, Wan X, Liu J, Meng M, Peng Z and Jiang B: MicroRNA-663 inhibits
the proliferation, migration and invasion of glioblastoma cells via
targeting TGF-β1. Oncol Rep. 35:1125–1134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi Y, Chen C, Zhang X, Liu Q, Xu JL,
Zhang HR, Yao XH, Jiang T, He ZC, Ren Y, et al: Primate-specific
miR-663 functions as a tumor suppressor by targeting PIK3CD and
predicts the prognosis of human glioblastoma. Clin Cancer Res.
20:1803–1813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zang W, Wang Y, Wang T, Du Y, Chen X, Li M
and Zhao G: miR-663 attenuates tumor growth and invasiveness by
targeting eEF1A2 in pancreatic cancer. Mol Cancer. 14:372015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L,
Sun L, Liu J, Yang Z and Ran Y: Tumor-suppressive mir-663 gene
induces mitotic catastrophe growth arrest in human gastric cancer
cells. Oncol Rep. 24:105–112. 2010.PubMed/NCBI
|
|
28
|
Wang Z, Zhang H, Zhang P, Dong W and He L:
MicroRNA-663 suppresses cell invasion and migration by targeting
transforming growth factor beta 1 in papillary thyroid carcinoma.
Tumour Biol. 37:7633–7644. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiao L, Deng Z, Xu C, Yu Y, Li Y, Yang C,
Chen J, Liu Z, Huang G, Li LC and Sun Y: miR-663 induces
castration-resistant prostate cancer transformation and predicts
clinical recurrence. J Cell Physiol. 229:834–844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yi C, Wang Q, Wang L, Huang Y, Li L, Liu
L, Zhou X, Xie G, Kang T, Wang H, et al: MiR-663, a microRNA
targeting p21(WAF1/CIP1), promotes the proliferation and
tumorigenesis of nasopharyngeal carcinoma. Oncogene. 31:4421–4433.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu ZY, Zhang GL, Wang MM, Xiong YN and
Cui HQ: MicroRNA-663 targets TGFB1 and regulates lung cancer
proliferation. Asian Pac J Cancer Prev. 12:2819–2823.
2011.PubMed/NCBI
|
|
32
|
Hu H, Li S, Cui X, Lv X, Jiao Y, Yu F, Yao
H, Song E, Chen Y, Wang M and Lin L: The overexpression of
hypomethylated miR-663 induces chemotherapy resistance in human
breast cancer cells by targeting heparin sulfate proteoglycan 2
(HSPG2). J Biol Chem. 288:10973–10985. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang Y, Liu J, Fan L, Wang F, Yu H, Wei W
and Sun G: miR-663 overexpression induced by endoplasmic reticulum
stress modulates hepatocellular carcinoma cell apoptosis via
transforming growth factor beta 1. Onco Targets Ther. 9:1623–1633.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shi Y, Chen C, Yu SZ, Liu Q, Rao J, Zhang
HR, Xiao HL, Fu TW, Long H, He ZC, et al: miR-663 suppresses
oncogenic function of CXCR4 in glioblastoma. Clin Cancer Res.
21:4004–4013. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jayo A and Parsons M: Fascin: A key
regulator of cytoskeletal dynamics. Int J Biochem Cell Biol.
42:1614–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Darnel AD, Behmoaram E, Vollmer RT, Corcos
J, Bijian K, Sircar K, Su J, Jiao J, Alaoui-Jamali MA and Bismar
TA: Fascin regulates prostate cancer cell invasion and is
associated with metastasis and biochemical failure in prostate
cancer. Clin Cancer Res. 15:1376–1383. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pelosi G, Pastorino U, Pasini F,
Maissoneuve P, Fraggetta F, Iannucci A, Sonzogni A, De Manzoni G,
Terzi A, Durante E, et al: Independent prognostic value of fascin
immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer.
88:537–547. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rodríguez-Pinilla SM, Sarrió D, Honrado E,
Hardisson D, Calero F, Benitez J and Palacios J: Prognostic
significance of basal-like phenotype and fascin expression in
node-negative invasive breast carcinomas. Clin Cancer Res.
12:1533–1539. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hashimoto Y, Shimada Y, Kawamura J,
Yamasaki S and Imamura M: The prognostic relevance of fascin
expression in human gastric carcinoma. Oncology. 67:262–270. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hashimoto Y, Ito T, Inoue H, Okumura T,
Tanaka E, Tsunoda S, Higashiyama M, Watanabe G, Imamura M and
Shimada Y: Prognostic significance of fascin overexpression in
human esophageal squamous cell carcinoma. Clin Cancer Res.
11:2597–2605. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Maitra A, Iacobuzio-Donahue C, Rahman A,
Sohn TA, Argani P, Meyer R, Yeo CJ, Cameron JL, Goggins M, Kern SE,
et al: Immunohistochemical validation of a novel epithelial and a
novel stromal marker of pancreatic ductal adenocarcinoma identified
by global expression microarrays: Sea urchin fascin homolog and
heat shock protein 47. Am J Clin Pathol. 118:52–59. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Alajez NM: Significance of BMI1 and FSCN1
expression in colorectal cancer. Saudi J Gastroenterol. 22:288–293.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Oh SY, Kim YB, Suh KW, Paek OJ and Moon
HY: Prognostic impact of fascin-1 expression is more significant in
advanced colorectal cancer. J Surg Res. 172:102–108. 2012.
View Article : Google Scholar : PubMed/NCBI
|
